Charles M. Perou
Fondatore presso GeneCentric Therapeutics, Inc.
Posizioni attive di Charles M. Perou
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
GeneCentric Therapeutics, Inc.
 GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Direttore/Membro del Consiglio | - | - |
| Fondatore | 01/01/2011 | - | |
| The University of North Carolina at Charlotte | Corporate Officer/Principal | 01/01/2000 | - |
Storia della carriera di Charles M. Perou
Formazione di Charles M. Perou
| Bates College | Undergraduate Degree |
| University of Utah | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Director/Board Member | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Health Technology |
- Borsa valori
- Insiders
- Charles M. Perou
- Esperienza
